VIRATAZ R 300 MG/100 MG TABLETS

Virataz R Tablet contains Atazanavir and Ritonavir as active ingredients. Virataz R Tablet works by inhibiting maturation of virus in the cells; preventing virus from multiplying inside the body;

USES OF VIRATAZ R TABLET

Virataz R Tablet is used for Hiv, Hiv infections, Human immunodeficiency virus infections, Aids and other conditions.

POSSIBLE SIDE-EFFECTS

These side-effects are possible but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.

Abnormal heart rhythm, Nausea, Jaundice, Rash, Headache, Abdominal pain

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.

SAFETY INFORMATION

Before using Virataz R Tablet, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

• Avoid spreading of HIV virus to others
• Avoid transmission of HIV: do not share needles or personal care items
• Consult a doctor if you have haemophilia or pancreatitis
• Consult your doctor or pharmacist whenever your medication regimen changes

Virenza – Zanamivir Details:

Brand Name    : VIRENZA
Strength           :5 mg
Contents          : Zanamivir
Form                  : Capsules
Manufacturer : Cipla Limited
Packing             :20 Capsules

 WHAT IS VIRPAS TABLETS? 

Virpas Tablets is mix of two hepatitis C infection (HCV) antiviral medications in a solitary shape. Each single tablet contains ledipasvir 90mg and sofosbuvir 400 mg. 

USES OF VIRPAS TABLETS: 

It is a mix of ledipasvir and sofosbuvir and is utilized to treat endless (durable) hepatitis C, a viral contamination of the liver. It might once in a while be utilized with another antiviral pharmaceutical (ribavirin). These medications work by decreasing the measure of hepatitis C infection in your body, which enables your resistant framework to battle the contamination and may enable your liver to recuperate. 

POSSIBLE SIDE EFFECTS: 

Tiredness, cerebral pain, sickness, loose bowels, or trouble resting may happen. In the event that any of these impacts hold on or compound, tell your specialist or drug specialist expeditiously. 

COMMON SIDE EFFECTS MAY INCLUDE: 

An intense unfavorably susceptible response to this medication is uncommon. In any case, get restorative help immediately on the off chance that you see any manifestations of a genuine hypersensitive response, including: rash, tingling/swelling (particularly of the face/tongue/throat), serious dazedness, inconvenience relaxing. 

DRUGS PRECAUTIONS: 

Take this drug in the dosage and span as exhorted by your specialist. Gulp down it as an entire. Try not to bite, squash or break it. Virpas 90 mg/400mg Tablet might be taken with or without sustenance, yet it is smarter to require it at a settled investment. 

Virpas 90 mg/400mg Tablet is a blend of two antiviral prescriptions: Ledipasvir and Sofosbuvir. They work by bringing down the measure of hepatitis C infection in the body and expelling the infection from the blood over some stretch of time. 

DRUGS INTERACTIONS: 

Virpas 90 mg/400mg Tablet is most likely safe to use amid lactation. Constrained human information proposes that the medication does not speak to a critical hazard to the infant. 

Virpas 90 mg/400mg Tablet ought to be utilized with alert in patients with serious kidney illness. Dosage modification of Virpas 90 mg/400mg Tablet might be required. If it’s not too much trouble counsel your specialist. 

Constrained data is accessible on utilization of Virpas 90 mg/400mg Tablet in these patients. No measurements alteration is prescribed in patients with mellow to direct kidney illness. 

Try not to drive except if you are feeling admirably. 

Virpas 90 mg/400mg Tablet, when taken together with different pharmaceuticals for the treatment of hepatitis c disease, may deliver unsteadiness, obscured vision and this may influence your capacity to drive.

Virso
Sofosbuvir Tablets Details:

ABOUT VIVITRA 150MG INJECTION

Vivitra 150 mg  (Trastuzumab) is a high biosimilar restorative result of reference biologic. It is an adapted monoclonal against HER2 (Human epidermal development factor receptor 2) counter acting agent. It includes 1328-amino acids; glycoprotein. 

Breast Cancer Drugs for Vivitra (Trastuzumab) is shown in which condition? 

Metastatic Breast Cancer (MBC): Vivitra  (Trastuzumab) is shown for the treatment of patients with HER2 over expressing metastatic bosom malignancy. Triumvirate (Trastuzumab) is additionally shown in blend with aromatase inhibitor for the treatment of patients with HER2 over expressing and hormone receptor-positive metastatic bosom disease. 

Early Breast Cancer (EBC): Vivitra (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing early bosom malignancy following surgery, chemotherapy (neo adjuvant or adjuvant) and radiotherapy (if relevant). VivitraTM (Trastuzumab) is likewise demonstrated for adjuvant treatment of patients with HER2 overexpressing hub positive or hub negative bosom malignancy i) as a component of treatment regimen involving doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel ii) with docetaxel and carboplatin. 

Metastatic Gastric Cancer (MGC): Vivitra (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal intersection adenocarcinoma in mix with capecitabine or 5-fluorouracil and cisplatin who have not gotten earlier hostile to malignancy treatment for their metastatic illness. 

Breast Cancer Drugs for Vivitra (Trastuzumab) work

The HER2 quality encodes the receptor tyrosine kinase HER2 and is regularly finished communicated in bosom malignancy and gastric cancer.2,3 Increased number of HER2 adds to tumor movement. 

Bosom diseases can have up to 25–50 duplicates of the HER2 quality and up to 40–100 crease increment in HER2 protein bringing about 2 million receptors communicated at the tumor cell surface. 

Expanded HER2 flagging assumes a part in expanded expansion and survival of the essential tumor and inaccessible sores endless supply of full change cause metastases. 

Around 1 out of 5 of gastric malignancies has excessively of a development advancing protein called HER2/neu (or only HER2) on the surface of the disease cells. Tumors with expanded levels of HER2 are called HER2positive-HER2 +ve.3 

Roughly 1 out of 5 patients with bosom disease has HER2-positive bosom cancer.

ABOUT VIVITRA INJECTION

Vivitra 440mg  (Trastuzumab) is a high biosimilar restorative result of reference biologic. It is an adapted monoclonal against HER2 (Human epidermal development factor receptor 2) counter acting agent. It includes 1328-amino acids; glycoprotein. 

Breast Cancer Drugs for Vivitra (Trastuzumab) is shown in which condition? 

Metastatic Breast Cancer (MBC): Vivitra  (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing metastatic bosom malignancy. VivitraTM (Trastuzumab) is additionally shown in blend with aromatase inhibitor for the treatment of patients with HER2 overexpressing and hormone receptor-positive metastatic bosom disease. 

Early Breast Cancer (EBC): Vivitra (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing early bosom malignancy following surgery, chemotherapy (neo adjuvant or adjuvant) and radiotherapy (if relevant). VivitraTM (Trastuzumab) is likewise demonstrated for adjuvant treatment of patients with HER2 overexpressing hub positive or hub negative bosom malignancy i) as a component of treatment regimen involving doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel ii) with docetaxel and carboplatin. 

Metastatic Gastric Cancer (MGC): Vivitra (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal intersection adenocarcinoma in mix with capecitabine or 5-fluorouracil and cisplatin who have not gotten earlier hostile to malignancy treatment for their metastatic illness. 

Breast Cancer Drugs for Vivitra (Trastuzumab) work

The HER2 quality encodes the receptor tyrosine kinase HER2 and is regularly finished communicated in bosom malignancy and gastric cancer.2,3 Increased number of HER2 adds to tumor movement. 

Bosom diseases can have up to 25–50 duplicates of the HER2 quality and up to 40–100 crease increment in HER2 protein bringing about 2 million receptors communicated at the tumor cell surface. 

Expanded HER2 flagging assumes a part in expanded expansion and survival of the essential tumor and inaccessible sores endless supply of full change cause metastases. 

Around 1 out of 5 of gastric malignancies has excessively of a development advancing protein called HER2/neu (or only HER2) on the surface of the disease cells. Tumors with expanded levels of HER2 are called HER2positive-HER2 +ve.3 

Roughly 1 out of 5 patients with bosom disease has HER2-positive bosom cancer.